As leaders in AI-driven lung cancer diagnostics, we’re committed to advancing the field of interventional pulmonology and supporting the clinicians, researchers, and innovators driving it forward.

Our involvement reflects a broader commitment to shaping the future of lung cancer care and advanced bronchoscopy, from pioneering AI to supporting clinicians to diagnose patients earlier and more precisely. 

We look forward to connecting with SAB members at upcoming events, including AABIP and CHEST, and participating in the Society’s outstanding webinar series.